Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor.

The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential ...

The early clinical evidence suggested ulixacaltamide could provide meaningful improvement over current therapies for ET ...

Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.

Praxis Precision Medicines wants to help meet the large unmet need for effective treatment options. Praxis specializes in ...

Katharine Hepburn had it. So did playwright Eugene O'Neill and Sen. Robert Byrd. Essential tremor is a condition that causes involuntary shaking. While it usually develops in middle age, it can start ...

BTIG raised the firm’s price target on Praxis Precision (PRAX) to $843 from $507 and keeps a Buy rating on the shares. The firm views the ...

Dear Doctors: I think I’m coming down with essential tremors, which run in my family. At age 81, my left hand and left leg are making movements that I’m not initiating. My dad died at 95, and because ...

Discover how groundbreaking insights into thalamic connectivity are reshaping treatment approaches for essential tremor, paving the way for personalized and more effective DBS therapies. Study: ...

CHESHIRE, Conn. (WTNH) — Four years ago, Helen Moser noticed her hands would start to shake at random moments. “It’s just an uncontrollable motion,” Moser described. Sensing something was wrong, she ...

Essential tremor is also called benign essential tremor, and it is the most common cause of non-physiological tremor. It is inherited in some cases, with the affected individuals having one or more ...